Why Encompass Health Shares Are Trading Lower Today

  • Encompass Health Corporation EHC lowered its FY22 sales guidance from $5.38 billion - $5.50 billion to $5.33 billion - $5.42 billion, below the consensus of $5.46 billion
  • The company forecasts adjusted EBITDA of $1.01 billion - $1.05 billion from $1.02 billion - $1.07 billion.
  • The company says that the guidance reflects the challenging operating environment and expects a substantial improvement in the second half of the year.
  • Also Read: Advent, Aveanna Eye Encompass Health's Home Health Unit.
  • Encompass forecasts adjusted EPS of $3.76 - $4.05, down from $3.83 to $4.19 and below the Wall Street estimate of $4.12.
  • For Inpatient Rehabilitation, EHC sees FY22 sales of $4.25 billion - $4.3 billion.
  • For the spin-off Home Health and Hospice, the company sees sales of $1.08 billion - $1.12 billion.
  • Related: Encompass Health Plans To Split Into Two - Inpatient Rehabilitation And Home Health & Hospice.
  • Price Action: EHC shares are down 5.64% at $61.19 during the market session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!